Status:
RECRUITING
Modulating Exercise Dosage to Improve Concussion Recovery
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Boston Children's Hospital
Spaulding Rehabilitation Hospital
Conditions:
Concussion, Brain
Treatment
Eligibility:
All Genders
13-18 years
Phase:
PHASE2
Brief Summary
Aerobic exercise has emerged as an effective treatment to reduce sport-related concussion symptom severity, yet existing work lacks rigor regarding the precise exercise volume and intensity required t...
Detailed Description
Concussions are defined as a mild form of traumatic brain injury that result in acute neurological dysfunction. Recent work suggests post-concussion aerobic exercise at an intensity level below sympto...
Eligibility Criteria
Inclusion
- 13-18 years of age
- Post-Concussion Symptom Scale (PCSS) score \>10 to ensure participants are not recovered by enrollment
- Concussion diagnosis by a sports medicine physician
Exclusion
- Pre-existing neurological disorders
- Exercise contraindications
- Concussion \<6 months before enrollment (excluding the current injury)
Key Trial Info
Start Date :
August 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT05434130
Start Date
August 5 2022
End Date
February 1 2027
Last Update
September 26 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Denver
Aurora, Colorado, United States, 80045
2
Boston Children's Hospital
Boston, Massachusetts, United States, 02115
3
Spaulding Rehabilitation Hospital
Cambridge, Massachusetts, United States, 02138